✦ LIBER ✦

Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts

✍ Scribed by Tomas Philipson; Ernst R. Berndt; Adrian H.B. Gottschalk; Eric Sun

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

FDA and Drug Safety: New Tufts Study Cha

✍ Rochelle Lee 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

The Last Prescription Drug Benefit: The

✍ Pentecost, Michael J. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 70 KB

The Effect of Managed Care on Prescripti

✍ Lyles, Alan; Palumbo, Francis B. 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 124 KB

The role of user fees in the cost-benefi

✍ Brent, Robert J. 📂 Article 📅 2008 🏛 Taylor and Francis Group 🌐 English ⚖ 141 KB

How Much Choice Is Too Much? The Case of

✍ Yaniv Hanoch; Thomas Rice; Janet Cummings; Stacey Wood 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Cost-Benefit Analysis of Organizational

✍ Assa Birati; Aharon Tziner 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 55 KB